Literature DB >> 359267

Malignant mesothelioma. Current status and future prospects.

J Aisner, P H Wiernik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 359267     DOI: 10.1378/chest.74.4.438

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  8 in total

1.  Recurrent malignant pleural mesothelioma: case report.

Authors:  D A Cooley; O H Frazier
Journal:  Tex Heart Inst J       Date:  1983-03

Review 2.  Chemotherapy in malignant mesothelioma: a review.

Authors:  A Krarup-Hansen; H H Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Malignant pleural mesothelioma in a nuclear engineer.

Authors:  M Huncharek; K Smith; R Milatou
Journal:  Br J Ind Med       Date:  1988-07

4.  Phase II trial of five day intravenous infusion vinblastine sulfate in patients with diffuse malignant mesothelioma: a Southwest Oncology Group study.

Authors:  J D Cowan; S Green; J Lucas; J K Weick; S P Balcerzak; S E Rivkin; C A Coltman; L H Baker
Journal:  Invest New Drugs       Date:  1988-09       Impact factor: 3.850

5.  Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients.

Authors:  G Dabouis; B Le Mevel; J Corroller
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 6.  Diffuse malignant mesothelioma: a review.

Authors:  W N Rom; J E Lockey
Journal:  West J Med       Date:  1982-12

7.  Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.

Authors:  M R Law; A Gregor; M E Hodson; H J Bloom; M Turner-Warwick
Journal:  Thorax       Date:  1984-04       Impact factor: 9.139

8.  Malignant mesothelioma of the pleura. A prospective therapeutic study of 132 patients from 1981-1985.

Authors:  A Calavrezos; G Koschel; H Hüsselmann; A Taylessani; H P Heilmann; H Fabel; H J Schmoll; H Dietrich; E Hain
Journal:  Klin Wochenschr       Date:  1988-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.